To view this email as a web page, click here.

 
You’re reading the latest from Dermatology Times. Our mission is to provide you with clinical insights that expand your expertise and advance your practice. Connect with us on Twitter and Facebook for daily updates.
 
Dermatology Times
My new insight on eczema
Have you ever found yourself on the other side of the stethoscope? That’s what happened when Dr. Ronald G. Wheeland awoke one day with an asymptomatic, solitary, round, scaly patch on his ankle. Read how this experience inspired him to take a second look at how he treats patients with eczema.
ADVERTISEMENT
 
Dermatology Times
Dermatologists as co-conspirators?
Dr. Norman Levine says honesty is the best policy, especially when appealing to insurance carriers on behalf of your patients. Learn more in this article.
ADVERTISEMENT
 
Dermatology Times
A socioeconomically inclusive practice
Dr. Elaine Siegfried discusses the benefits of serving the underinsured and encourages other dermatologists to consider working for a practice that does not exclude patients based on insurance.
ADVERTISEMENT
Advertisement
 
Expanding OTC product knowledge
image description here Do dermatologists possess the knowledge base to effectively use over-the-counter products? Dr. Zoe Diana Draelos tackles this question and more in this article.

ADVERTISEMENT
Don't Miss The Aesthetics Innovation Summit on May 15!
Join other clinical, corporate and capital leaders at AIS - taking place in New Orleans, LA. Exchange information on emerging trends and learn about exciting new drugs, devices and technologies. Register today!
 
From our Latest Issue
 
Dermatology Times cover
Can I charge uninsured patients more?
 
What innovators in dermatology should know about technology transfer
 
Facial care fleshed out
 
JOB OPPORTUNITIES
 
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.